SPHK1 and chronic myelogenous leukemia, BCR-ABL1 positive: Given that the K562 cell line was derived from a CML patient who developed acute erythroleukemia [34], we hypothesized that the BCR::ABL1-SPHK1-S1P regulatory axis might be erythroid-specific.